Baby Genes, Inc. was formed in 2013 to fulfill an unmet need in the Newborn Screening (NBS) and Newborn Diagnostic arena. We are a Clinical Laboratory Improvement Act (CLIA) laboratory using Next Generation Sequencing (NGS) assays focused on reflex/diagnostic testing and supplemental newborn screening (NBS).
The Baby Genes mission is to save lives by providing parents, health care providers and public health departments a more standardized approach to NBS; one that screens for more conditions, is more responsive to current and future needs and provides more actionable information.
Our vision is a standard approach to screening newborns that does not allow a single child to suffer the ill-effects of genetic condition that is both identifiable and treatable from the very beginning. In addition, we want to see a world where the early detection of genetic conditions substantially improves an affected child’s quality of life.
Baby Genes Licensing
|College of American Pathologists (CAP)|
|Clinical Laboratory Improvement Amendments (CLIA)|
|Rhode Island State|
|New York State|
Baby Genes Tax Information